|
|||||
|
|
A SARS-CoV-2 oral vaccine development strategy based on the attenuated Salmonella type III secretion system |
|
| Authors: | Leyang Wu Lin Li Xingpeng Yin Chenyang Li Wenjie Xin Lina Liu Zichun Hua |
| Affiliation: | The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China |
| Abstract: | |
| Keywords: | attenuated Salmonella ΔhtrA-VNP mixed bacterial preparations SARS-CoV-2 SPI-2 T3SS |